Medications Settings Guide

  • Updated
  • KLUv/QBYlfoC+h+3nymQRGSYDwCAjVmjjnoqWiIXdGC5qJ6KZWvQj5BU+tRBcTMiEQBAFAEAEMwJ JAolCiwJeRkYPrHnCKgopCo8djFXcLECH5LwAcGgH79JRQxe4EPiMcwKWzEpBRLZRBWbH4K0s58h 8eqckOjZeHZpRgJZigGZmCi9VyoEKX8Rvw4EoxA/L4M6s4G0S0/bBr62M2WUVfQXTBlMJLHF1H4O sS8ipv3ReD0kBRJV0zExBFz2CPH8CMHE4YJSasW0RxEmMVfwcUlVOOI2PRLBIMj0wvrBrAZ2fkbP xQFJDuJ71tO2ySmQ8jXrlPCJt2ZJlx64F6ed4Hwl8ZbkdXgKFZirtiSRG/QgGwMkY0Cg9Bpw5OT9 eoCjBhz5qBI9QDRlrqDHmldfYqYWS/thR47B9W5hR227BXxQ7xa28WMavuOZ5gd4PxZ2bskW1XyJ 55Womg9Y9fzt+gf4Nf+uV35jFQ3DbFE1H8Tx65LfWlTNB3LL1XFFn5Er+oAkruhz228GlnAsd8tw Q3bB9meJqvkgvu1e//i2VV5UzQfxZ80xFk2/sRtW2S8/X6JqPqDp+La/643BYk2j8z3Tdh2vVm+s Eus4AL/lD9cepd+4/gFaMvxdL836P46sZsm3Z/Xcqun6Vd3wrZoPAFDPLxqOWyKr5iKrXpm32GrN X4bj1md5kbd+XIut1gyLuWLVK/8BsVXs/rZo0zVZu/gL3/Ir0gL+Db8CsO1f0/TMFmkB/nXPYuyu fwB5Xom0gFueV6JNf7um6foHgGsJN0DFsb4Mt74k/gF+LNo0GcO3yKpXsvzO9ap+ZVgl2jQcr0Ra QGeJNd3l1b9lWIytxJqmT9V8kHiJtIAfq0RYzDXgtkVYzEWLNU2LtIB55apnkVWv5FlLtGtWLdY0 zVcx/Qog/vhd2SKrXsUs8ZZb/def9b7sOra/fL9xS7TpPsfE2Ov6smpmi7fcEmuaXr10bF71WLRp DrfmmhZjKx+A+0odDsEnUeJY/37nllN9Ak78iKEZi55FWsCP43k1jhFuRFnyK8MZT8vRcNxyn86E Jb/cLX+Y9dYubM8yzM0yp/Z+8g+H+3Qm9gvHLAffMstZWO4EcTgLy/luYVlwJYD59WnVvxN/AXCH ews7r+SJK/q8tP1j74bb8OrXHVs1+9zyTGF9VWziij4CPsgVfVZz5pZniiv61B8z3zPWFX3ueTNy rM+q59X3jFzjY+z72zb7Y9V71zMtYDLeK1iS4BqkkYA54oo+XKL1M6RpniCuw3LovQV8UIeeO9x3 vTOX/GZ+APh+4+8xF/d7fwbccAyrYBsWcfe3f92hcBJTbAazvsbAw3Y+a17Bcmjkvs5JLKGQ6lU9 ySJNT77ngkWeqsV7vuXiq1qqxbtKWS1W6RP36sf/s2FtC2eSKlq/mgFvTNuwxHPO9w7bs2cGxd/D vr9m6bluXdw9m2GrWYbZHAuuXdyAlfzrl7blt7451cKqXvbXcKqF7T71pefuGX3POJxqYTnpqrnO /VjF/fuNZxvmuN4trIB/c3mGXb/mBPyYjs0rjobjVf0DzNwPUH/71zRsrm+b+zIc37M5flVcgEXN u4XlLxy/HHzLL1f/Fnd2C1v/23493HzPWM7CijDNQlkvfZLxvILZb2ymbTh+53hecaz6nVV3/XKq hY1nMdjm6k+/NKdaWN76mRTlnSxTegapaBz/9uxkypFeTU0Vfbng++WCTdI0T3mG7/f+dPRM7Rqm rOT3tmGJS4YD+LAoLeV59T8CPku28Ngls3/1UspIWaYuGX7ZsPyK7tbPoDxtu2V47nS1p5xZpqgq 8o6irZ8p0dQsWd8zm9s4/m2X/y1gcr9csMfsnnPOU/PbrRYHPVFP3vDqpTn1PMeUX7tl96eP3K2f SdXUBAD8iePfkvIMALieKygWXLumr+9PHM8oFhaWmOfIyPW79TOx+b5nlQAuACVL0nNVVcX+CsB3 M4ABifj9nnGA/6t6Nn9WcGz3AFq2D6Bl99h827NVAEYAxnu/kh/Tsddm9A6rNvf/1G8A/+VZTrA+ bDXH8q9ZMfxaNez6DYCy5UNCjmMCvH3/z49VL1y/Ad77Zb33j/W3rtlxFr8BPmuW7X/PVHB9328j 9sqswqcH3J81y4vPmuU4JiDB3bJl5FSUx5o3Gc1ovF8u+FdC7nvdLJhAwByh57pFuaJPgnPJcH1/ Ru7jou9mYkD9yjN8r2AGN6I8bXvvV6Ky5Amq9KW/bTgT6WjbqqNt2gaAkarz7/vHb4clT1Bqg2t9 ychpW2PUNtaI61zXNs+I4xuL4yYDTsPxzgXAde6A49yF49o2YMRxbWNH/SS7ydWOmmXnqsg59TTV 1PTleaolL9OyPM2O+lLtKnqKnDNPtVRL9Cy7R9USFbm2eTiube+I61zbOBz/MR2DP6O2hdyPvZuR +0x3PHtbX2KQ0DYGJwcwy5hR2+wfD7g/d82qi4UZ+7c94PPjFXzXbydmw/Gsig34/ABwxmbJP159 7pq9a/Z1vx2Z8+G+T7+vD8eSZzMdm/8Nzz5c/Vky3HrdbyeeZ1A8zyDuZc/qCLeCX/Rbu+A4ftvR /eU37twy/GbqV35jWwVnXqv7DeBTzzfMmnBy/e/75QLA9+rTdv079Bz/APIkVs+tL0lwH/frN6Z8 NPyKCe5zyfDqrUFcgvvu1T9QcTjWBwBcz/fqixLaNrdkCz2ba1eGXbO4g0o32uaS4VuG6448b0x6 dv+Pa47nuiPDrm/f8o/F5pYlTzxP2z4akXNNi/Lyv+83pviyp2Y/UVX1Kvdq7zwVU86jLLh2Uai5 4FSyLxgy7IJrzne9HQ8N4MMik/VRLHkSgPrvV67/HbMoFE25szw9l5Yqd6Jm5zhKopypnguO8WHR DJI/zUHxXnKlZ9wuVABUC0bd8r/luUXJsOtHUGi36z/gzcRmm/SexbP9Pfd31S8IZfY3psSfNWvU zjF+/K4+31W/GVTpLewNy6H6xzMP52X5uWsWZX553nCMAD4c4KPI8uS4aXKp7wsuJRcxDDJF8zRN z5niafp/vzEd+yAUaWFtWP3G6Ln+TPIMw67vMUhwPOJ6OIbtkuH7/p/vemMWFMoxvuu1QygyVUuO UX9VbLZhxfAsgvLdwnbufmP1TPkxTEGZFtbTtgDmOP4k7r3l73o1nPwOaDmGXc/x3Nr2X81155Z/ bLaaJaY/zRNVOeei/T1wxfO0zXeT893kOMc5hoA54pJhljybI56nbWRKnp1jfADAtv0GkF8Ny5Gd oXLdcz/2kXeO8e9XIs/w5wpgi7F5tZjpX7sC2Itbhms6wTF+fMMgz9O2L8F98YffCPfj+bWCNwmO Uc8Uz9O2Lpai6TmGPMN2/UWo1MJ6nrZxsfTc50nU8/3Wtz2LYwvHMer5fn/dep62cVwkF181s9jF p9N5AbHZpT9uR6nMtLjlwESNIr7iIsdKxZONIr6POvDYR53H/bjX22UlPEhSXoWkNOmS0qTTIWly moCS0qRPTt2CtE5Ok7U06Y1RYiAx8BIDiURikNCAI69nlFiCLbGKHnmZnNHkJCuccmx2+jxti7EK 2u+DFiZIh8iIncALTXxEaVMIJlJ58jGPoXB6R2pWkz6DmEG2VlLPfxXsT2STslaoSz98Ni0K7weU AlJZOP2AywuACzE1qw8EAZXhCaXX7drTtoNBzZBi65GE3UVcgR3k4BV2oINX2JHUy0S9LLoTyS66 yUmEGpAXnYvEv8V7LAoGEfl14mFGwu0zzroZNwhv1WcmmeVlhNmLLbTqsIcLNONHsf1IVTuKbYuT RqQRyVa5YtsiiaMaNRqBbYLR4mWC0UowWrOTA+Hb0UgRJhh8FGUlkNBbnCaJDgSS196c0kSUIVoc /ELtLMMquk1hFb2F2T+kkD8uKX/cj7vSpM9oBklVeIt6Px9R70e9n2O6AcZjBjllqoGcXfrjErt4 mWogL5j+uMQuBEx/zGjVQNqX/vhM8mWb/Ms2+Q9xSNwmn3hMEg9P2yyiyjb5yqxBjex1vEcRb3jc HRSuYAdVXPZ616jrNaD8cV1PNvjL415B154jsyb0LivhGtgpzGWBlAEO5aXMRoR30rkrSCHpkETS IWkFJydXXSeS0qTTIWlCWJAmp4k9R+qQRLeliRySGgoFAaGoIayiHzorGDt0Vg8nER5Y3IOhZnXn 4BB+gcOabRY9FHZCjaocLGEnEDoLpa5wcdk1g7svqVSJRpjnqZi4i0SiFQQQxcvchOIG6IGYOoFK Sqpdl5udeyIVTs4ZoSxOFELpK2EegyrxMvnYSe1EJwCTwGbHaqIwi66FrWDXYaHCbvYZJDoQCxV2 n5Mo7Ag8krDrDYyiQy3SRZdBDZ5E9zo9DnCkmHjwwPF9iOWdEE/bKJlXB1KXVg2rguGFu7GTZrRM Niw5au4DiaKMnDSyVR33QCBF/Cm2LS62LS62re41injaRhq56rogjSIeMVqIHAh/JhitGuUO9BqV YLT4beBAeDHBCBOMBaF3Tni7p22ihvCGGsLbTUKXlUiCkSxDeDvoEt6OCGWIFk1yRSPRSDSylCa9 lSFaXCFDtLiMoXEgvAdh9ucOcB4brKI3WEX3tG3RYBVd0WAVnYTZn8+iWUSK3NBoZrCK/pmsovsD i7egEWgEGn2fSLAIQUXiS1V421Hv57GOG+u462cUS6QqvLXnCKKQqnAEhsbYc6T0Qg+yG2A8MPTn CD1IDP1heuhBRjwvhlZ0XuhB3h3GA7yYMtVAzi79MYvcFbzIVAOpAYkeZGf0xyVGYBhI8hITLQef rOSuoMW/KAcRRb8liYenbQjwNnnLgaVw2yZvOfg62TZNXgSLWw4ODBV1Xdjr3XrUKOI9beMiKoNp GEhP2yquDzNJPMAKATaKeMUMVSFVK1jxFZd9GkW8bL3XggSjNZIhWtxlif7B5yHUWzDAHAhfuKgF Ee+yXHX1tC2RUDk6FVZBGN7ustyRA+HrFCYrBzgGYtviYCISkjKvar3JionMTJ7yJkKNA+ERM5RF ha0gxZ4jMq+iO8RWuat7E94xdH/uaRsENUpKk37AuHRIALM/n5wOnrbFOu56EDufFxakDKY/wImo NAkZBXi8Q9LhS7kL0gpOPG2LeF46JM1iiubzoUMi9BanSe7aABusokc878AMpRlgPEAJxyP5r7Hr zAbCSWjhD4QvSP5r9LTNk/zXGGlZRZ81oTdZV3DAtU2TLjFw1RUmGb3eIVXhnZCrrojOCkoIVA54 9DzzwiGfw3zorOCARwbJ+2UQ9lDYISBWgl4jnjeeUfyZ8SgWbefLlMoGI2QUBkglqkHKBk/bKqlr sJmMBjbpJ5WetrFeP3MAgWYK9zEKwfApDUhlaXbKCoXTE2sIgGJPzWpP2wyfMkEQiN1G5jUqKylZ OBxY6sJNvRqY4xVOT9tGFoUwIpVzJ+ApXqY9igiysGo4qwa46DgQnlB3GAOpPSGwig== /qkc8FjQCLQypGjQCdT1bOQYOUJONaNBTIcKsQtZWMlPOXL6Y64giBkjbbsSIy2F3yNEFJgUSEAk SoGEhD5AlBZxjxCvP+q6IyBQQmp6xuGemq10T9sIKnczjpf7QLKchfLzXz1boSufE5AUmI1AwtlE UUZOf21nxl5rgGDxVrFoPWHJgRQ8HgbFyxQQW1bhpkAVU0BsH/YACKyYjQTjpHBMeMVkfAbfsZ3w 8JfDV2nYyUFRshy6Q+ajklfeaC39xTMbAyvonVYKLDYQ8SJYhe7cBwb05KUcDEmpG1UeASgRyZ+L KsQg9NZBAwZDqgzRskMClUMlrahWBE7hbLQ4Kv+Qwcyq4OBZxOl9pTwKn5YYlg46IrzkM4XZIFRP z8KJ/gOvBQ9d4TxIWEWfeakKf4lifYDEmE+HUOVEvZ/HrglK/ZlQSe1RFAcYjwjjwLS7y/zZuuaf cuSy6q1rQyeAaRkGMrUp6fBlLjD9cRIqDfBuDyy+sFDETzlyT9u6NWTXYSdg6aTIZ/CWusIJPm7H YbZrx4HFQahLP8gOULO6/aiQZShSPFOqJFaEV7yZgu8jVSgUNZMxDizuadtkYYJ0hMUmvcTgCQ+R OvDj1fLCguKetpGpyonRBxuCvYhtE09LFJZJOiicFhjHZDINnFCTVSPBPAg45ya4KFHhtEfR0zbC hXYIQCghj8wQbAEaI+KugadtA6+PS0aIEl+BweZXMASb8KE+fGFQ1rWnbZz8fAyJaHw8m/oAwpBZ CKpJoeGSE4UFQwvnW2CQ4TQ6/wrB9rRN0RdohgsUUGClSclRbh6VxIL0CAu3p20kNPERLHcJolTo 8pdUthoZ5hVOislE4Z62cXzMY0BdFMK34SqFk0il+yOI72V20oqww8xrVJ7Qjg0y7PrrBBCf1oh6 2rYBLU6jixUyUYzPoxKZapOnbRMVq+ixi4JKN0UgOquBMZcHFgHh+5Qjv/hVqfa0LWQ3NGXmgsjM BdejgTkeg6YQ7PajPG0biIAovEQq1VYjNRROgQen8JLHoEp42mYQU7Oang0I+0AQgLGeWlY6QWp7 2uYXr+dUtaFbZqpTNYwcMD1tk5whE6cfWFzB8ISyAHRTu/2oCk98ypFrJJ+pHtkNCenA4rFrrqAq RZp5N9XYfpZmSLE0eEv16/Q4NvYcAT1jQKBEYaORw5IS4TGsulvZHEgCCqn0C0MCg8Tak2cswOmq z+oDCungMFoc0SpS3tM2AgXGAZ4Rz1vhtMBHr4fOXcFOzZBizCW/biZtvo4CW8Huc/AKO8iktOgU G4Gv44grsNNQfNj5urYzd5ohxY0oAOOe1CV6Bf1m+oG8KaQ3ony/UhJuZxktzfi94BDEk6L0PiIO EfLTWTASgowGnMwi9ZcUFOcKpilP29YU51GS98ujWLSgOwCzpIVDPu/VTenq0C1sb5uniUFWpjSx hCcsC7KnbZ62yUTmSmGUdd2hKKeDEIgtKTwPRsbbJWOCsg9ipj2Ksm9CX+39Ef0dRXzkazuT0dbf gqBmSPEz6OA2gZC9I0czqVl98MYsRRHDUBQWJdnFqEbcntfx/ahjkUE6GAPD3Y1i4j0BiwxywZBo z0gIBzSsrcK9i2CjkSNSXdiFdf11lZEm7Fgku+hWkl10H4oPO34ShR1jI/B1FFFcgR0GtoJdBjEu us+ktOh8RPFtKD4irsBOLdh83XkbyJ0Y4rGURF8YzYmvMFCdvUPuZiTIaFWH8O5AEl4GA2IvCDL9 W8hE5grSnraFs6dtCtTKIyLh7L1GkgchgqRGmQzxtA02Sb0TT9tIFiptpb6Os0gXXYMwABLQsrDj nrZ5jySEkVowyC2XPu8pmGD4JQxZ/Eej+LAURMeSsNHiM7qPmMQvRBqYbRWL1uO4GGRiBlkHfdS1 p22etnUYj7qWGEShteJpm6dtMbZSip62mW5KgQTBYE1jhPQY3qJzZgqMT0yrhqU7JY+0IbNm9NrY 5wkwAgbE0zYwLEx86GmbjJSAWJjDdSUliQHT8LTNRqCipCQjYJG2pQvdYbYmYBH4TxgQT4ZRQFFi F3cFD2vjARJUD+zSgHTTjaIQCIiixBMYaJeii9OFvEDc3tO2jR3psYRiwzGLhB1ZGaTDncrE07bS qQWxKElLMkqyCQNiMLSm2XMVD4QX1aUYCVfXrOFpW6VwMbUsj0GlrGZBpRjueoRwOu9MYjipYpOj MtWTBg1qQTaps8ISvN6ZhIfmkL2Y4ENC2QysWAinQ3ZDihBMPBcjbSXlkEAdYcOK1g9mFZXuw05o g8TbBZlmNHBdohdguVS9U+kmfqSxTb5BYiX8iKKMfKJAhVZP2zzbpXidHgf4IrAKJiLifScZT0WG vrrZh/W0DVarv1ETiEDsqwAGJ3ZBHBOfkvFQS6hV6p2oJC3JKNCHlmTA0zZJV7Mkqa7MENkIIYLU BwrcQmSU0sQjOUYOOjoPzkriZY25qmRHq61THlGCepUaEAVq5bmnbeWnNOm17L1GmUh5CEAIidmH vZwGFomnbYmDBohNmaaEYoJ0OBFZUihw1BKEqbM99kBL4mmboZSA2IyAi8MWKiGK8uKcqUkHulEU iwMjgnyRzXlq+DhfmKyiyxqEP7A4bH7AVrDj4grsPG1bpIsujCi+rqX4sNuIK/BLFIDdhYUKO0oZ gx0kUQB2G8S46LxHEg6AYFW/gKlM/2D28xd/Ev08mh0cPFDePjB8xsIMZEI8n8uEKAbM1fOo9I25 gp2yqHSKTIgjB6RRxH8Wd+Rf6478U2zMFeS4BgTKUxZxPW3rGHMFHxiVyXlmZbGwVFsRoSs4Ynoo 7BjQsZo+dB15jaYqPITZiB7kZdIwkCAjhMfDPYLHUGxb3NRBEF6cSasM0foq5gqC/+AjKjfKXEEx cY88UXY+r0nmCi5k78jpD8kxcgPo8YVdhTEDuwtiXHSJgs0nomMv1tM2A4Mg08OJJ4LEPNV7bMTA cAmiY8nZkor+OwC/H1OofY9clcFWk4MHH8jEgLuCpslcwQIfYdhy9BCAgGyvJYkrsYJzApIiXiRd N3gpTbrIsoouFlIVPhrcAhl/GBi56oo4KCcClBBCdjEOAu8oWRRUKKEHqTILzBVMNX5CKV2PUEHE q/wLc7SGty8SbGnSFymr6N0lvF0MwUYee6kKN10qi8DM5EmsBL1WyIKI4uNA+LCQqvCFiPD2UFKa 9FD0qEYeEw8s/oYZVYoEmStYd5kGBB6tvpPCIOLVjLdLApkFsTQGfbWpxiHEtgxH6PS0jYdGD2nk aSGNIxzK+Wpb3+k3UjKNkCKH1OitooMW0sg/0SDKoAfpR52R2yzb5LvKNnnu6YxczHRGPltYOiMP TVbRwbaj3m+FKwopH3JHfsdUAwmarKJzjjuOGXfkdciB8KcFxT2BEPcrpCr8Y7g8AznNTCJlzTwQ PoQIME6TrmB42sZIJFjclCjXkffxhdsILXqQJQICDFsZiSbgKIpiG1bMFQwJvcUVFXMFFTD7Jyom omKOhVSF2yVzXRRSFR6iRhFvkPzXaJIcCI8x+FCUUszwdoulkqDMvFACnggIMKydmWNsCrk9NUOK qrgCu9KAvOjWGP6602FcdB2SXXQN2Ap2F9gKdoR3kehGBJqwm5xEYTeaUUwKTygKQUiIhEsOFGwO pEz2v1PYYaX7uf0uPmPBEUN5UeaJITWH8PbRBNcUsDTpB4cMupiUfgVxag5q6bB8UgiDmJrVEtlj 8UzMIFsTGlAFPW0TrTIFX+Nl4B6I2RB0m1OG1DJD6PUpe/wRmY8M89hZ9DEwzhOJMHoobOeRRRDf a+VgHZQMSymQ3PZ6gM0nz1Jgn860OD1zacaRQQWSM0eBho1dkt7pNJXwrQd24Q3CO3fMFWR9A/dA IArbyRpP22adQkAyOlBxDmpp8VZxIbEZVQLBg70OF/fT8SJxIzV0Rt5B0bkKTCJIS91UOBUWvEDc vq5vTznyRIqa1SK5z+rGXLLrcVIPJDQpjhiRKX6THhRvjU4nziGoTPwLhQU8IVoQ8JnjJOLxzUW8 9bJDXARbQFwlNR/++jGHu1qxDEdtLBm+UAdcnoFnCmcHMBTOWBxM+HgwmXBP22YYDAJJnoYAqMrW BsgeOMTuVTkhOlbREd0BLHld/XZA4EXgHiGwZx2YEHAglxFFWZJc05DuMmtGEIsDkp62wbakd8qD 4ECullbVKRiCAzkxUG3Ozxn5LKY0Hu1YZy93BWevEKdgJBVIC7FtcTHBGEUORI1yR6PRqEbxBKPF RwsCWYlgpCK8vSWgCG9vR0JvcYLwa9tFK0O0aBJNcknuKvIgzP4tqYDZH8z+XPEPxBbxoV4yg+mP z+gzElMV3sY6bqyD8chugIGhMd0LPUgMzQg9SMQA4wGGHiSG36AHeYmVMtVAkrPLJXZJYPrjIjIM JKY/Lqfl4GU58JaDl8ViObgliYfNgHx3BSsVe70rFZevuCqu1MmnfD/5lGeNIn5ySng/Sw4diUPS IkqSY3LPDJC35KweHYpZHXYcCG/wlNBkwkWYTeqppAWFAfc0uKiUZFN6hbMjgKFw8aUQvjI2eCS+ l1kfUITtzU76uUSVBREqKLgkTSHYJZLp86AGjYJ3xugrSQYtY62kHZKoYHseGwlhZVFKo44LPiQn mJodoA/4kHwuvyAhuIyRtsMkIEfl1XUdHrItMQRTQIUgB7aod02FRXlZO2tGEj0CScuF5WEJwoLC i5qGnSlNesRWkVpbddaoGiUruZ5cEHqLXBB6S1YiGH0EBB7CS8pKbskV1SiRSCQaFUoIBKLFSW6L CIVGoQPhwyo8zP4cZv8RZn8+MItcT/H5UO9HoN6PoTFe6EF2GBrzYRBo6EEOMB4YEkOPs0u/xC6k TDXMLv0SS5QMwyV2MSQYBvIS2kbhTDzP87Ttu146gPllc7+eb/vXLu67XvrfL/cDvLZL2+ofw28N yoQUKu8oydNUJdGSp2rJO9e2Vj1VX5qnqaLdi2ZZqmZ5qmWJiihZelTtaMlJNC1VlXtOimovtS2W +jI9T9XsnXOVn2KKlpkVh/YT5ann/ExL0pv9NDn3pypylNS2FZf6lEQ7ybn3psg5yXn0TNPUJHmq llwk1RXnydTzkvPTpyKZdm7yUyxRz51mN1NU9Zz0aO9m6TtXuyl6k9S2GHp6zkTTjp5k5yqJiv0k M5z7jEpyXpok56S2xXj3XVW5SookyZUlWYopSmqbpDxNtUwzp4qeHVVR1Zdc7aZ6mqeInt0kzbRE VbSrpIl61FTLVi1LfqKmV1OVPEsRPU/vfYp2jqZeLHmpbRlta1NV9T5VVdM8RRRVTxU9T5Wr6qme 4pk5O6qaqkpypu+kqXbOUVUtey/RVFXVnpYiypkoqZqpyfmZ4dK0o72bqqqeqXj2liNRz0mTVNWU nyJX+amWqamqp09F1SQ5fpppeZ6pqqplN0U0Rblpll1VVVM9xbNrW0bbWtSrPFVVVQ== VbspltzkSJ5ynprqyXlpniLKU/MsUc85R1Px7F3bWrKnPk1LzjnZRVMlOd/N8iTFkpccenLT+7MU S25mOmmqJ5qmqulTsfeSFNGT5EiOmqpppirJSdFUS+61baZIOz9NfppqydEU9Srv/jxJzs0UFTnq tS3TmiVZcp+i4nlyaXmWnZud99Pz1PRiiaKep2gpkinZSY5y7zvnHBW9ypFk711NOT9TUjXJ9OTc 9/I8TZ5y7tWz5KTvnZdoFznv/fQEI+5LcCcPoVzRp6VtLXdyNfVnqao9RU309Kqqem1rvVfL0kw5 P80TLcmT87LkolmS5MnLs5Oqip6miJKktmVa7uRlL0vPuXmaIkl2TjVT00RVVeWc9yXKu5mqvORi L7VtxZm+p548U5WfXuRlqqYc7ZyTaSmqZufKkvTmSaqqmZYdRc2uqp0sxRLt2pbxZoqqqFfVbp4i mXZti3Hel55EOeeoqYrn2TnVJMlS7aqKlqSYetJznOteJVGRcyVPVW6WqD/T0+ynyLnTo2QnyxTl p9o5KaJlV0/U7P30vYuc86nv6VmiZupVtPQi51KU5KZ6mqjJSzI9RQnXtc1muXOmbT+AEce1DeVp W+OuWRTnvo7iGJzEEspoRuNdsxOW49omZ7ivcwltU2U4znGT45xpei71nVPR+g94Myx5gvLWALCe tqlAnrad2rlTMVfOSBN2GVoWdiMWKuxKhUFCTTBaXLbe9EymMijKur5l1ahkw16qFZR91YlWqT4v EaIr2b5QKCgYcHnCrKtJM9nTNhjJfpHqTyrJVCjSCvrSXCKtSJoKj5EIdYc0d2CdUel+zbL2YVB4 2vY7BSdV54TqlDonUsfTNlnU6brY35/UmWxVYRaVxBOroP1UZG2gIJkKxASvE/fIZZ9wBfm4liZd XEuTDlbCFVysfhOu4FeOvHKoHLqZH5hwBCb84gsOnadtBduHXmZYsvDPQwCsHQOSTemNJuHzg9Gx yJyVvhkzLlfZJr+guCOfISDEFQkZt0dUokcMUw3kAmOu4ALMGLBOk55grCJpFPGS0cst5kgxMe6I 46qr2JojX1RChzly0GAh8WMIsz9PoN7P3wnBg+Qmq+iLl+JzRi5rDuOBxTm0LHwILAyxz3cKUmH3 UpfPRwxOCU84LZuxs7CvHqtMMAiGQwHJTKFAw3adTGSuB+5psCTphR7k6jSZK2iC7oWjNupARlRP k6JoCAsR2lg/BUV0m+XBvWL19x55AtLdzk/3ShzdZwzmyTQpjyK7k/e0TUWyYKoTjBvARrCRLzyw kqUaOfmqRm9RV39SdQPVyD9LRtX5SDWGVBzVW74FVPyB+og0cpZFAvoICMVN1YH08rUy4e1qKpUh gYVUhRcECisIkgadURHqjNwgG0VGTmfkNYfw9jTj7TJVORSUzshRkM7IZ13oQX7d4458dmCb/Fca RbwiPLA8bQtb9+RwR37qnHW0mNrV5FgtNyPUKjOtxSLB+P7B56j381FMcAMBNq4uV9jpj6dtcweF ooCp7B15XZApHqnEsCEMQCBf2I2pxNBJYKsIMS66ciPwdYc+0yEI+BUmvpsVBiCx9S0hNWvZjJNO XPWDDzchExVhQgigVNhHoNQnw34qMYnffJUYcnkzmrFWYToQGe86fEZA+d4WmTpL0gxQSIjD9FSg 1s/EWMN2wpWGhY0Mn/EzdliScXKpuqdtN4gDkjMjvPCFwCsEibWd/2vKzJJDDW0LuZFDyzLlTFJF tW0NwAymKjzEuhoGks8CF8nGXEuX29NEyO3pgcXRjLdLTYrzKD+GyzHoKYSpbJNPFFKVdh05bSG8 3QRizBUEbzXsH8ZcwfGFCHtbgpxaBoxQSwCtReEKFpSZFl9ATFmC0eLlh/B2BGqOnHawip7oZiGB cVdQDA8sLhOBF8LbPxRl5LFL5JcmPTKiJvOk75dt8gKQhWqCKIE87IoQSygmUMthYyLS9EoOpEGj DPkDOZq+ZeaRkUObaa06rMIlxhFP2xGkfFlwwGqkvC8YfSnPDMUzMcrPXrWCYoG5giKkAOU9bTMJ zBU0XR71fpOTwcyHYglnJemWAoknMFdQdFQkPiSAsWafTxmQRt59Cj6fYJlQdlOG1rNuhEABuzB2 DjLXEWSuno9BxBuQ06eGE0/bvE/suQhiMc7Pg8wVJGEfzQhSukHBilNZ9VqSeIB8wFxB356rPmDQ LAbMFVx0WgUOeCdV35gr6DNnpfPNxlxBzqAXm5V4csGXkHH7t3lZDAvecrhEVg+FKq9VpGQeYlyQ U4sjvszjQHgEwxz5DClNOqI0R44oIAihBym+bJMPWRWUX8BG8uckCNy1BDFHrl5MbcZ9Z5IRCnxI PG0rV90iTXRzbM9V3wi8jsVqgRpWYac9bQNBl4qEKLyTSiAk3mWlj2vtPY9K75mzwimLyggxVEQG vShdbg/Fk9vBRMglZNz+ySJul5G1gaJwRiouwe4Ww4K3dNgdrrCjpzDtsQG5EXhDMBN20GvDrrjV sH8yfyHCziGn1sgItcQy42mbp22Jf9AZCzF0QBBNFcwXGR0M7LLrZrImtfAUMozxAMcyNas9bUt1 Ah4JoVPYCmo4q4IBlz+5JeHtJQNSpJ6Mczf6NCDhc0beZx7GQcm58yoIIArv2ITiRkHt1NuTEhAw kKDMgceaJBOtjBAeJ6EVHhMkR3dHlD5G6rr9h5Uh4nUkSU14zUJgdhVlx07cHSaWeag0NJXxWFeS TDE0I0IkAUgA0xIAICAgHBGKBqPptscHFIACRTguTkZMLjQkFUrjsUAsDAflUArjIJCCKAgyppiC zAYBUQ7/enVdSlZ1mz96QgygDkFUxUhH3f5JPjZ61du+gDFRY5KCd0abTAxdMIgYKcs0yZUFovWS 6r/VBG+DCEDPhO0XCynh6gYaZPTCT8B5U6bOWvx4mKwyrAQOIsVIuMk0lEQdczkzsEydV1ieGhDU N2JkZfSDADXF1WOb1sDl+K+bIYxKQct0dlCNNVwpPqhNjgxwOqEigVHSUqjI2NhIfqVWyikBQQ8E Bcj+3WRZ4RGCTIVnvu2zHG59AhugDcY8sLBsNPhXEEB/uBq5xxK7WkBpuO7UOV8skXf++VN3vzDi s+CPAipu3Z4GE6Q3ZkUWn+dsI2xnG3z0jXKmkoSyjq5xy3jr3asFG6ctXJ+mC5d67P9W0iM5ALgi +N6jV7qdfgFsyryWCEcWnR3qJqvBJ+oaFolSmPF82f31Xl9TpDlEU5sJdzdbrEqvuYEnpjeMuJer QY43ctTKh7B6w4idEr8PLONV+hiEkMtfBk/tfYE4nACRIbDnDSZT+N0KNG3NmaXCw5QfYDSmdKBS Rp4KHABQ60fCBrQGm+CRXcObFl5QlvHvlTSFRMAoo12gkhWF/7gFQtsfXZjk8Qn9teErnBCeskuq oVKDY5jIwXVTDpk6DQA+fFOepUBbnUD124SDQxmUSQrZ9fafF8G6GY1YQKD5+YFoZX4cqrb9OSwt QYKIfYFc8k9JHW4KcUGHlOzYn0vqjgSPEv1la1P3vUPJi2UkIGFiP3QH5rjuyftK29q10iV2u+pU 59YPfcxlL1IX4TQvT0aRHX+FqUNmmMdt3zBYWP2OUOkQ6HroYoY8AHUIbg9B4bAW1CG4eggK2kSo Q1j3EPwzTh36fg1MNRI9cT38NOl1fRsnr8snt6yTv8snKX7CPmAvzic5DmuFwMfKSSM/Jep8ArQ2 bIIKEy+f0AwWFcMbRz6JaH6v0TCSStoOVD5N/UifKQt45NN3hY+femfEmfLzaf8ibvhjjcsnqzws uYwJ3omEdcfwnbuWqbacbJvMsbW4W1pkfinqxGWWxEMYYClBfSfClIeXai52JSH89JokW7YaokNd bfj8i0i4TkIcTcUniTywzJrq22D90kJUMK2FjEasMlNoZRF33knyaGnDvI0V2/QZFvUIU7zLBETL ioUIqwJ0KFQkK792g2UjzKie5E6TUmEnELQGrdvw3REbvagQXMGX+hS/kW2wKUKvEm+caGGtPnCm 8JIyf4RpoHdYeSlWcDDAwcCtIvYs/DoDvbS+FbFrFCGCNTlKigN4BOJw+9P4lWLjCZQu2tpge5+y k8oQACR/RKq6iQCBUS7D+YDLBifx0GgP86hVPCN/Kw1RAhNRSqY9tpiS2fH3tDlJiuZiejFsiBFD HS2wwdrAWREuzGNRHRWiBCBLT3yS1VMQYlAgJ0O+/6RYnLZHS39dLsdmamIBQ/qWcdMlswJ96cVc Bw/+ZziZORuJZhXBHqvQkB+KtEcgFxPwLXpAdMLnaUEv3mm3KhVi/f75E6IFcrF3GqBSwOfv4k8z xT5p47ovxuGgCUUc8sJTI/74NDAOgKSa4XV52OS/hlAPTPoUn2oH9ElJMkLXp72n3Daefw4TNDpR Dg8R5rWZ64VLxFmMq/s22G72d/R6dWkQSqs30EK80EvZZc+m4+yU4VMvZGYXXos2puW0hECUV20h qNTDqE9PLOaRrBhmXBjqsx0uE85kgXrVAKA+vYor6nCBLJN0HjWWLO7XqG+mAEhTfA67Ynb/DoKu FbQ7FuiFF40uqIa6aFT7+TT0T564WyUYTv24otLbCp9NK6ofV6Zq2HmkxB9ykJzhxCo1+gN97/KW GfHNOEoDOFhxNlnYWrfMHrQ9jxINtYBTSytVlHi9CYUTlbdQ5Q1tmBFnT/9eyWA+jBLHsZNKgrpH ZelsA5HZnXl9ygUPKToNM40aoYGsRHKZH+26c2wwSXHA48e7aJ2F03iNn4qQPCiys2VieXEGCxgc awiKOiyPRsaGyUlRH3VzpD85pprGZdxb9eCvWBCDwdx0PBjDagb2VGWfnJxuIP9umHxNGVqlAg6E u/Ce6h/aSvoOtqA0OwUw47LZYExFdP+UPe5k4Ng9oWTQReaPCWy9JzDxHf+zMOuywBRrmt705T/G hV9QJUKXjr3uCRsXJlQeVfo+Z7qBGQAmGPeG8XIYhuCmjQZQ64fLK6cUs+D+7zkqfgmhvqV/5v1Q Ky3Wl/1JINRsZei9+w0CkxOXqSBvJf0rMfoL1nXObuRkceiF4JwsT50IfAbbBcL/vaZ+/3sxGUf3 LRjnEiFkp7ot9yGaFAXcMwYUxFE9cFeTfou0iKDqXhF6z22HaCuRTi/ofNxWjfLxnF1jb6JA7Bfk Pgg270nazlBbkn43SDlrnEMcgLJXJxTCQENygy68oQ9yC//L2h2dBBobACf0BsbwtZ+0DsaAIbhV R5SS7JH2lb6gSb9AeRhA/EVnAM630RB3/iWtEAoE0L2MvM5OiLnfrYb2emWmQJO7qspAYiUEysBu zl8Bg2qZPYCh0eu1QQv/rVLgnqKS1hm9YgyKAVW0FOB3ChGWSpalSPXc+U35k2j3v1NrS5cwcIFR lPvaYbFFUx8nPDIjIltxqeuAJ02cWZDuTEUc/2xmUzxr4N5FkK1bV+TOy9EeXPoWeQ== RVFZJqpTr1t7KU/m3wuXgXHQsSInNU4HxGTVP49eCcfxjrWnUKJ/d/RWiurwpPEOQRzSS6espHnL 1/k2XUr5nRej5ozF1T32vC8YeAfj7VcYvrnyfAFfikkiw8vVVxENVlWyiHzvCVHL3wBcT++PbHdT iKqsof1EjkNwqdNfF5LR9TaqqQjIm4chhPnnhWL+CBGz/hNqUScXA/DU1qokspf+vmXEidbgjcKg 1hpdhKUag0CrWaSIqCsYqp9+1INBLwwbpG4dVbkgC+xUG+6VGXVaSYPbhBtegmnkGyCERfpG0TZL 2MTxGKYPh6AzMqU4UDniEx3yanAsZNmMzVuybhYWLC3G5+Qf3asEgksCrPaObhgs04GfjhMYtshV UDbrRbgPCpLdDyjV+gsUWNj1/TEbArck5mCc657cRQ9Ww/GwI8p1OYgwar3Qc7yeZZ3aS8pDLPjk qiiyvJS/wqzV4cNMuvIaJjrQe9qXxHY4ZwBDmDtm8hCelJq50fEPc3n3izVogMhT9JkYxJF8ob+I nLgPrr0SWwh0q/3hggokjfRCA5NBpgWyJX+VgcB7Et9TvhSWXdpOhlqeUYQ+HSVog4F3gTWqpnoF 0JVsWfS0YeGaM4HQ7RQmCwKbbBW38Nr7BQkgAjAQuEXJ6RfzoGDh7sQTOo7IyRKK4oawa5ZfZyVf dhu+VeSHJEqmitcTfSJkkFBiNoFI40a99cw6EbX71LDFlgujlsF9cgpGuFz5BI69sOF01YQuWhmF RC6t1vwtKdckgKinB2K4/kgdK9lTnMsb1aPxjUk2Rk7ohDnurtt0BbfgzKOIjHG4bNqDLx0mxrF8 Pj13YEcIuEMAFRR3FV33/LV2KIXp151OFr6Q/H6V8+ZjIC5YmxRM/q98U8hyapmOi+beaA/zE0Oe tdJSPqSI3knaG3tUOxMACYoZ4Ma/EBRAsUN6A31Z5ta/Uxb8v1NkJiA2XAIxf389QH80/QJjqEy7 hkT3AV6URA+4Ovsxp8UU6UVTzJRq4y0F+GdbScyEotsG7Htn6EK0OkHuU9rviMwdnBrih1DlNVvU MPS2HU1aExRIF7kiKqBoOWtSogUynGXXPvXQ5UJGNvoelZUb06eUowHsFZ8+uabS1sUYfntDDQAd IVO2gfU/QVa7fzflmCGJuQqHSJqyuhn8rIVgHi2tlLqzqXqzBNCu5iYDm0TfjB+M/vmGwmwy4z7X Er9IryJqSIxtAaM9aJD36XrFFRQpklMAUTbOMyAjmtqjpmdNbqQ2FnYpxv2gDYyAENDfOIWAEs1I kBZyey1a1m3PmtMC2adtYoLYnZ6WzHxdL6TPon61T/aCOHZ4QX/gqBd026p44l2gcACCf8/xU+aS yTap9jtmLrC1hKWdw0y0n1hb/m1E0cuWzJ9zDZEFwpAjk+P6NlKfKc3g2JDdnWfhf15hrJlr4xpV sC8itV8WM46q6z4CQUWVNHaRhg2Rk88sdz2A9lRUa4jpuWnb2HoYdiqJreR1bNImGfSOO/nvbNWW THi3gNIEL3sNncAEjsse3q0fFNakF1HU1niErVIMZOi/3i2C5I9bW26izBS7JfeZAyJt0aZbsP5c PsgE1sitKxBLQmOl9axavZB9CF/D5mMe9PP8jnXGBmUYs1ZmjHFPY0O0EwUB0gfBAyksI6iNs8D/ nv1IJKxVeZ2Ta+M4EBk7VRnAqvaBsxH5OrJWW4Bp7Jviz3to8yGt5F07tP3IQ46lXUqtd+O+R+tx 8tS4Q5CU4tL9BkqnxH93grt2HbrDsTQLuBKkNS1e4ixOGRYskNypuM51Gp0iS6Xdb3BbpocLZAdx XUt3URS+gNRo00tRHu9rE65Zy6oyLHng8AGyjrgco4U+tXJHsY3Jm5VOJ9adEgfu6IVoixR4jULx 3p992cTnF8XHzkxNygH2C+L1+hyDmczpOg0VTBWDUS8vYWIPPv1v/g4SkFBJLqvX4jHkK7cq7/T7 bqes6SP2nZ7Ne2IvqLrjC+IZODoxop02QpfYZu6Q9xIRHXAkf5kApCGwzaFHbRYWEUOKV+8vcAg8 uRnxCFNyDc0ppbDN6DsoIjPA4wwgrifBEqIvWr+ceeuHugFrNodT//s1pmXC28ER5U7QdGuY8oV1 cfQGFlhP4evPdzwoVBo2h1Di4rdNxWuKJ4PIZ7OfNhSJBvFlWfdpeeAUn5B8M+W1fYHiIMhxAA6h r7/rTxWTbXRe/mwuZYD63klq6b4d3x1409/5F7ycl+CYeLHycsxOOb1oSDXY4KVBg8weCfxKCNhN 3l4tehg01kfL5IFHN0X1fSam5PHfbZ5w4mR4INMmiHmrO1ZZMOI0RTi3RXVRT19o9dnhKlLLAnzr 4kErQiY/n/AmLWR63EWuEUc/W/jsgyCtA+r1wqvc0abz03cO9sWUBP6RO0nXyIL1UbWFNCoQuxB/ P1icW1XI/iQOUmm4HIN5Nfjd2XwyasQHlpG1OMqaW9HS50v7INUyuZIQcbTa0nYUxAF7Kxbmg6zM +ZUhG52qm2B4arg8OazULJEx4YIsRxWEW5MnQBrlwJfYR5mBuMnqSx8h8bQqXWvLo9+dF8eHrerm KosMwFR/vvrvQDc0YG4qW/tUOMlMoRVbfj8id56GR6dOOCj6jcUvsOmXVGJOroPUl0AFsA3VxzxA idk5KPAhGhaOW7S52zNGZjuVMQg0RZ26Ijv04uQrdYqSag/YVOXBXL7VDm10RIDiu7ys/OP3rpT9 0Z1taEsLEbGFgEPDePe1ujZkQMuUIny1BsDbdB8YHDWf9w2ECi3fyrXymEJr1UjBQrAEHIb3TbbT KN/ayRwIeokORt3BkXiJn0b76MaoAj8aJPkhH2dwx9zvSwpjEvJf/ufR2N89M7eo6HKFYCoe+Pni VzcPibh6Z9wvN5//oPEB6MnvitgRm6V9Bfrdg6RaCJXei2W9FyUCq21ENHebrGsXxoWMQkP2Zl2I 2cLio61J2G99VtgW2mYUt/wjtbYOSjIR+ht6Zn4eeRCaGQpIq6BX9YteZsj7JUUeKOEf7YP5SCYf ReqBEthspzXZZO4fWLuEcJxf/PMiX1LqrBsXA8uMsF4ckF9SBeuzcPn8drCkXC1KVrXPBPwh/+o3 EJ8V8SXVaeHb1EjZnUgjTkFoNpkp4KkjtPyi0cvFQTR0ivUrkE+WYepaco363HrcDdXfGt+MmfUo xlk4Tke/jVFNVH8nKUZwJIVRHgDpF/4eDTiJhtzQv586Ff6fBNhkDwAzPUKHtvlgu2A2BD2wdLJA nBbZiNPa9uCiXCYzfQ7LF87GTb1piVf0jwM9HEFC8NfBg1Y875zqvAxKNjc/xRzFhssg4JHhdADB LdWafAF9mpylMwNOAgyzxLzOJrUhkZcL16UMoQe0xAZZ+2xoiROWWrr1wgXYuy/jak6yag4Iica8 JXv5Ctn6gLKMkrkgHi4L4nVnAtR74/9UwRW3R0p0mLWSXQx8gOiORXyK0hu2JaHk2acEQiq4hrKH yv2s0Q0HHCNtYpgSAKjRAInEt8VLipmp/6FvXWdCjo8vB3GioIpo6sh8nzXtqrh0TR7HyoywX3VN /myp9zUKsEwQxMxPy0QLwyEYxGtyXcdpvGNSRXN6XmuVNXnzRXsdBSskl+00KehkVqAETYS6UGuT SzGpcnZ3xbgbNCmccdZ2XNO1dG9X2LrBsB/3d56NSY0DOLmh008L/jasl4XEvI8ECqdJyb9uHaBi UriVgEreGxdbRcekgithNdX+t0hsKklVUC1Se1YIp6P97R8jFtm45hCfJ/UwZJDXHOWJ2cpGCkDA SGp85pzeNcSEmx50qd+HSkRfoAQDUY2P1OYTL/rndJBfU+15Bl0vw5EQOUtENBiDXGRmpsL1qeSD kyUUv5pLZBq5O/iXi+UK8wLPBIRc7UyhfkAbtco24xgv1EsVAW1zCGdIG7j/fq5y6W/m5OWMslfU 4JVmiT6sdphkB13W+iW8GhUMwGOcxCDxk9o2RBTKpzQbrfXhFGy+aHLi+/BHNdW5FQ3I9HjsFInQ lSk1YdLMv6zcqWtKMWEVPbW2XWRCgknnYxWS0ukozSnFYVnm3wnQEYxFKADvQqXJtkYWikfTTpDV eMG35UWhwCIYgIuMH7g3VLvBdkFJD+Oj12wa2sMrzVj/k1VkqFJWxBLJAyeQmCnAy94qKa4pSs2R ZpxlyY9vRYnmUmyOJ5FuKCWfx0zRSseU908WGwrsoXPaDFaSyU08AqwedfwH9J03CzwBV2OBY7Ub lpVBn5qnI3Im+FoihaZRHOdzYI2p+pe1CTh+M6dIpbQ7cI7jqGxS/Ih8KeuZyWzY9m5Y1yceRbj7 Pi5d6D7RTsESpYW6WunyZLzYuLKw30aiDsJIKAaeL1mJkooLANcGcl++SLecweo/15j4cD9w14wK rlwyrgHIm4/9Cv7SHmpwLub+UeKHYd2y5YxBBDlYfVC4WSK5uD1qHc0o1d5Rox/ByiyJ6m81Pur4 EM52vJS3d05I4OgZnYjkKMlTJw2MKm7Xg18iZhhMRoIZ8gNpt6qKwbdYL1Y9m06vaKH85nQpKT4+ wbWsOhg50SV16fyVLckBW1BNU+qtQXWezkcSas6KEbbzRLnYVyP43yFH2fz2gcKxFWWUeKp+Nh+1 5NmMwhf4ZCO22vmHPwCbOURLz+SFQlNxFsalijR3dSTJwwzL1B7lilzVEjqU62iZxJwzPhdnB7/D ayai7MORqITYJFQ/IYpBiFF/h0N84WtLyQnGap6EpNih9C/UGZYQp6sCmfjow0jcz7VDPJQXT0T3 BVg45ESUBDakLSXE2sEcuC4Kh5AdnDBEuQ1IRJUrLx4s7+yYiJIxY2EWtUWIoUGJKEJPyW4DazMm xDpFxRCq1cOHWGY10yDEnUVtyrnCDnEr8yPagPNIiM16iIkqh1gVHoRYRBZyYjKcsUNsihSGjwja c7YZD3FZDE5nCbg5xHX8iIbauyTETX78I042qCcQ4sLnErJVutkhNpapYAnGBEL8mXqYgQ9BREGX ECtmRM53iF0uGnJIiPWoB8Ujms2Aw86EWExWH2x6iK8/LPTJ0HNAd4+F/GjVQYgDZttavrDn7kLM LlMQoo6GmRAm2bnXLBQO/KfZQU4JheCllpdSV30hVJhWiLJ7jYN66n0JlWnMB44wjijb2pw7HB0u d98BN1pmv5kAvQC3PqgSsn5x+F1gvrucrnF9LZ6QsXEuV1ryfPGX58o5pIVQtR2+a+Xo1Tm7Rozh bQ5XqPGibe6CX8RofZEP+3Eb8dei+o3677500aw0OqTbThmCTZ4/XUsRo+IRT3LvTGXMhKhNx9c0 Z/Hdu9HoPsrSXD+DU1wXeVQk48KVxzr23s81djeybiAESImbkylSX6W/CqxP8S22pT7oOhu5eey4 Lq3pW00v+P/w5gAf6OLkW9mvwieSwDItb2FOYiisLfxtXDqnGgt+JD2MVYoxkJrKDg== b9fX9Jx2500HiiuVBJIlrkFku6GsjSWplkOV8H9qGZe6YzoxIeNKlQ1mr14cOxbiychdc06lJGjB txd7NGSjsDc5XpJZS27GAZ6oZnSNERBkIELge2epWBPfSEWLMxoVwpnyEzV0g76hqbaskQMDIO7X aMZBtOAnh8iAU3YPXpCISRbwxCoGLcigTfgqBs1hQNjhHjSrURI9Wz4jqhpsBbbD3mu03aWqU4P9 8csN2lb3DPYda4LPuDI6g6f9M1xhTQqQ+mHiYI9Ts5GVPDW41vYJsGnIGRxRyCA3+EngGQzkqL7g BjmowU5tc4DARmYsntAAODH8tm0mc6NRRdJUfrhrXDn57oAQfvIb2Q61I115cq9CJJNkRji0Cobr +Hpoq/Z2jjqRHQBfw4OEYazkhORcAZfqIurGtjdea5QycQHfISaaqjU0AnluVEwXrDmY/74uEXXQ rITfwaWy39wzPqO9Y2gE+hryrGOJb6Eo978aYho5ASXtNB7FoTwML0p0FLMCwbO0OpW4CQ57LQqX qH38jxFiuJNr9DbyJK2uY6tM3ujAQNOnAMhzfS3Aw2mTiWdAnnFDKi+T+XbdRZhIOF6FJWjM+Xul 8lWjxJiEqW4U2uun6KgnK3htfXm8dfBZI74h/D5gfgFaOM3gzIfei9fYICBhnIl5Mwi+KUa6vE5s wl8kVm0jrzMv3YRisX87/pDvI2ph9oBFVBmIiCucbmMonGeolapm3MUtSNTWXWZpr6RbsT6v+4cA 5my9f/MLP9vih+994j0uaZbvPqMozw2aZmlh6B3eYLHE+3JscCWoIveBj/0s2rzBt9vklW4sUR26 fST6rDcY1kBLu83lwgZHWR5NRqp4wQaTRNTWkSN8GigbrON6GITjN50oobzBzdVrt8EGZ4DXYP5f 3RlwP5A0c1IoiN7ZEpc3+GdbP0BtyGGD2xPCgOINXoCSP+0eQljf4OyleRD21D6M02Yb0SBtabAl EjwWZAjUjgIDG1cpjeEfRstyDU2fJ3x9z0G+vYzuQUWntyWwXFu4Ix20s67cyMocq7Rz82exdSiM gtQcvqWbFA+58JEI/EaV43JWZgWU0ICkEBzW95PtVlT8vRFQkvsM2Z5acPUcKSx4DN5Odkk7sihr hThc5iFAUAtCuVLMdXLsGtfE95xWly6R5P5HBZY5v07NAB+YSUPI31XInpHiMgJ7wEww7FI26qUE timFTI3hiCJEpbMfEcN95n6F0z8lmtdJfNo6p401WgtfvwmqGc0m3YJqQcNNsOriKXwP5iMZU4y5 XeEJ6r5jMmvdowRGWA8OKzsojMgph0aSc+xoUDhIc1Nuvo4gjIH9Gb59Rr2GmCg+VtSPM8jlyzAV K3W31YxOnUq2Dw/PYX1le1KoIgYypXH08nQugBcEl6cRh1Oj6NVflyHrVPPsaRWGj41B/CFYG5wC 2KVHH/nyZDArKmTtqKKWoQgwHpUB/6mgvQ/t41n/jDMRemfMaj6PzyyAA43n34APCDAWUV6Dyskf ehTAyRcHHtQTsrkfMlC3gqGFvKynpuUjhQDHw84OU7q9XQCTv1lkWPajsAB2sIBxVUdGeQhPBqcs gPeHOVWep2B2IsBoHNPmU0JU1jvdMggw3oxXruhLuwCOijq/H/RhRb/7Oww4WYAHjKIsdX1jfJ9e rxK6DdzEh/Fw0mbmkHSUhiSPtSqzA6eicUS9IuOFjDXXqMyhkw9HXseKBga67U7zWCmei1oM5bJV GvIm1QQC5TrTcdptnCjJWT8XF4Wb5iAXOaqgOXd6GOsxqS4t0jwJilVYWWqvDZlBCC8lgXCiLN7n QKAUucZ20ivvVn6Os0bhrBabADBynOhqN2wqPgCh5IEPr9HigKOG38b88tsg04aX6EIl9IAv/Nd6 azx4ot0Hzf7Ap+hRrfXU3znMMst248anoU4+7tSO66gJw8gWagKl6aDrmH7bXbdWBjdK5kwKDH/I 2RlVpSMimmzviCNsOOy6iu/5TCAgYM5Ra0BPoJDulwg5QEeNmXnc10GXgMv+uETU+/PEIpVVsf5d srjHSudh5ESU5tdffaanjFf02d/Of+/tQf3IlMyW8VXnI+1oGP5n4RMDfnlKL/cbK9PkhRiJGLuj 9oU2NKXS5EttoDGlX0M31zNYKnHwkVJyeyoHQMdF68+pPQ187CyMrlcelXmazN3/gdPXr+SG9l6s LN83n1P51tj2nGTu/dn9gryoC43Hm9lvGrzJyANwtf+d0TRESkHZAojwQw5qoQL4Ei+1Bp7uxMIK E7xxFrNE0SM6InAJcUyc42ZVggDnfOzbByjlMwFyhSP+GVr1+UZR+DHAXtJlSS9w1GEsdd9mIohB Uj4CNrcvXqz/6BifQ6yu/7M7DZcuirsKDQ1j9R0UUFVd3xwiA0V0G3P/Y9QRvDO0YH0ABIkKtg3y 9DtVE/6aZVAjgyAhUmmROMsJTfgpVivqu2L3nFAaTmw0jk7gC+lIWzIP6KuT7fL2BI7ABQdN7vnG PtjJcEQUT6q3p86GSWtKhWmUhFCGgfTF4VN3X4exCF++RbITL0hI5ctIX4EKoVe2eD3EpoZfSIH6 HJT0vaCvaf18s/m90+g7CqpNNjsFHD90bCZoPUKMWw9fDsurNlp85nnz0KbJ5A2GyIqa7r3uQMEa q6b+x3loL/+JNDm5f8ZCCGWZjG5ypXsyEjSulLG2QAHul1wrgnK5TgQS+GBOvpbTxuJ8RT/SSIYz LBcNbxqQ7/ITEArAyc3gclpFXbSUBZzNyVuH7gyFeamB4dRnF6AHNVQ2u4V48pNlPfLRmEEVSikj T85GMAHi1V/l0UsiYzLuTwILY75Kch1FzRRl7qPemTZ37oVbe2cSsxzaoOnjv2iVAl+3u3YZ1yH4 wnaxi4nqcvLIxAyS7Asa1k82I//42xXNiTepAVdFbLfNyGG5R7spleQ+RLC0o2RLsJIh86nYOBOs J3GMcZMC3q3xqYj07q11js0+RH+O3WFgJXQip+S34ErvPIxBiKizGA1jSc94wGs2S0s0agp/BZZg gEF7agrz+1ZfS8RJPFdYHOhTf0Iqb3sscwx1lCo8j4tb4QJO9OVoSXNs86O15xJeKMX4bD/aBGNF JkEvcqjONSa8udHTtt/wZ7nV11ckSjM6BcrHqOurE+udIor2GkNu15dC48jYsMDydhj1dVy7wbi+ 4bVzKg/o+s6Ssf6ec2Hqmxdf3y/UtNRc0bq+lx54r788vhoocJ3lKin+DKG+5LjY3bm+RsRzPBLa 7APpH860N1DHRn97lWoey7Z2zRR5fRJ5cECAKyYeIwmOOx+6FzKaqg7IEHGNSRNXqk0TDg5xgqv9 84kZHLHadD9U5DBOldotYLIorTiSPJDLumNhgsO3tVExSg6kPC2OBcui32cb83amdHDMl6TCLkgv 7XJJCO4bMm1/dwnTTLImmy2RFcPDmb+XXFB9tmmWrBXKJFqpUGAtuN1Gk4ffTtu2nUgMslRq7kJK 1w5M5Ll6DAtYkhKiB6FkpwD+vLieYR0rttE3TPjYmBDPBPLUaFjcHZnfnB25Jnh8QChTp/4Vo1VZ frbibgwWTSvDpxEWcYJavKMbFcjxKJpkVpdWKLzp9yM63oYXFN/mLiqfiSCVInmzpRhZ3XB6IdNW d4G/qSAif14aGwQTQsbysOpyq/H5vrJ+sjLgs1zOhJHKlAyoPzJ0+OrDWhsXdnB775DVP6nrrwia /axG59SlZI47dfn3av74o9IQnKe9AhyCkwO/MtGbB2YcbR5SZxxNGyxmyEK953l8Y1X7FNIiMvlB Q9HsZEjNe7UVjveNy1nmVHbhaxlmE1nkXG4OYfRih4azsU2NkapAWC6zP6Q2PdNzwROtmtuzEwoj 2zCaZGjq0HvFZ4z5cS3ehmn1bfZhWgeWSkpg+MCeodA7eZjMvYQSJh0wdtcAJd50JwE06zP4nDZe KpOCJx4DXNuw4g7sgTLC/CcuBylY6dVgFdlhvJDcOnWvLhMtJjJBYb60NvMvaRJl8mlHifG5LorK VjSgFB9mMQllEIsv8LmAWSBK0w/7ubehUFslirOONtsQ4I5MoayPYqrW/lrm8kw/NvvUKgYSGSpJ 8oCQoXv7l0gUze0EWIqsYWGbY3w1t7ZKNSnmxej7uVdukcVBMRwjrySv85JSFbGlU3z8p8ysh2jv NCkVyElLy4vbglrlE+FTApLa8awFvPAoVaYDYqUp64gp2BGC+v9NgRb5PHf/X9DkbWCGM40i9imx l138HsPorT/TU9U5PCFrLHfpHeBWSE7UQoB/d0RNOYTYaqMFocSm+00chfQbDkjNvprEuuNLlDI0 ybDPTyvY2R5cRcw2FowKlgHzTJCPvuYUOJHrFzQP2sf1A30mrmDVkyyvO4jhYnK2DwoT9byqePgJ RpuSkiJ5AR9tTzw4LJnkI/ln6aQaaGSmrT+ldOaNIaG8vfp7AXy5bVY6vle6Vl20ilyjPMnvOHCa rF8L7BDbR5k9oK1+dfc9N6j8IgjS/JZRm/KZXXfLmZe0lRJGuWkC8hBWh3gPYaFzUPdflP8nGA1e Xo5F7P7tE/ikDKctFUrr9wb+DO37r0gqWrH1zNUdLQQ8Yljr7QxaMkHSGD4amFTxH/HqxWHIpBom JZ+naJGboswiBLrTQPEl3mHP3gpRxiLYJF8IjimAesg0onsW4mXl0WVDhdfxgYD1CF0GLd1N19OT RPsM2Qv4wHslWhZDEFC74S2ZJwQOra5QsbWtUjIhB+ZxvkpU5WgVCmPmVXHwZ7lPp5ChnVGVV2la uV+L4528cOViQQO0vDcvMWyNwtcXb9m0KD06apvTinCBFW3GvUMmxykY9Gkzlhg0kZD+2mOxcycL bDNhhQMeRdeXlWagtDNItF2eAt+Kgo9EguUdQvIs/5sQEoAB/uuUqgmzd/jcyASMswvIbrj/0sjY hslS4IAYyN0jAxNKoi8FZiehLYGp2vq3h7JJjmaZp6dwyQdtOgyu2uqO123wGMD2D0GA6JqKQE4i MVnFbeSbrhOE9FFj2CQ5j8zCsA5zFXHNx5svDGBlEjPti493+TNU39PkJGAr1f52illUGU0kv5nx hvkT531lkk4FaFxZpiJpQOcJZfyjMTf0/dMgWapIm5AXa8A+d9XF2Yn3UgK+VNsNlSqEej9wgoT8 nS6wupzfOsZQKSroeq8LObgf7hqcgtmvrS62kForSKiEi8SadUwqZ+Kzw5cO3pDnCjn4Mh+HgLui 14yEa57Iaa8kpUromON9E4PD8e2aukrXrVOFTy5GdwJC1ib1iJLQ1fdw1joKF2X0xgpnoz7s7/vP 1ZLDIddYyLhyWdTcNQpnuBRUOqiKNitf9wqnM7+M1oMCQnGWo56Yr1o9Q40jOHCQFkUtU8+OQJCK Y1qtvwxjFCEEGEXCYROMsw5ZYqnrmN6NAfYnc4BSAOba6BVK7ZQZmA3U0R9GhmpTsQ== UbHK9QhsjoqS5tImn+UyJZ5eaj3baTI1eacWjqOhM7da8KT5PTj+QGAWGqwcw5ENgqA4sFaRClav 8eOVuozbpapmbrL2O0jy9h9/LKqkNNXi+cJA9fstHNCcBbsKb8vFguYAUbQYc8rwtg+8VzbHb+c4 xYOpedTIa3Q70d/1Nt5WeTzdbZBBB+OiZEFjarJ7MwKclO13daiWCmFenfIJPR2LE2AzO4paLmcp gIq0DicotbGtD6m9qZkEar4DyXX/aU4twmDy1IQihXpxFSyCvCZtmcvaTOjrmQChUMTWtryOfOtD gKO9cIhkTA3sWgzfr25QVz5zmUQDlXmvAmjviGkjBJjlvaOLPrCDZYMBO4UHFu94JbE0Izvf3/G/ fuEZPt3GXI/tWyMM/IkXvg5+xjfDr3gjAWSwtwAiXXkrmMz3FpLU0cmTxsdfKPTSky6vDCKp71Sp MARBK/nOzO148FxQ456s5ToQMGjPMFjxIjVl7kD2OLig5hvDPPEIhZAmD/xS+t0NLAUCaLlhR/bF pRAoG4YTj7opoulw3rQBwRC9C7wgTARTaIXF5FAzLr4m4MwRa7CEo0NMIFVI0TRx+dgABNTQgr6r SwAtqnYOGJrSGIgEaTVlxOADkjpFLqhC6jARJiKa8FaEbF0JEkHE132uwVG235pGSIxTmo4B4E1T IJ840azKz7w7MOGGKidebSxjyHDkwRVTZegDiUOmcKYdDQh/mJYU7FOOTiZjD5n7NdLg87Y42kME bAAtfqLnGiZwLPXvMStHvoKG4GOOls+xrroFpf1itkFDAuNl+O+JqadhDGNt31q+k+BnzaAw8GR2 W+naQQtWvEVBm5UDnWBaG5PbSDWzNjpJRFEqQkGfKdlIW2kScRCa4+E1B5oScXaVF71ApnEazhQA 6oSr8Unn41Vc4uOIHK1QpCRM3qPgQ7YtFW1C1hcfOprXIYpCmjrQ17NnBV8OnI7RcJMwOdQ5saNy ULtLuAd2DV6BDMexA/Fkx4/wBYDCCraxVIzKgEaS2uuD4OmNpa1Q2C5F9bHqqu8Ndw/sODZut4yc l7EGR/9jFxPY957wazB+9ckLWHdHnZGknckT69NphA1GGWFArVRWe5doGKGfPwEGobPvWLGadUsn RXwmeyeyYxYLwBmjT4xN9ytOILBsLAeuWPNjkKEClT8G8QkLJvAa47qZSvVV1h3kvXsjxW4F9zPn 81gVlWqpY9nOcLb/e2kETeOyAAhCO2nPlfoxapAcUnSQcnd7/egFzhBc6mUDXbkdGCFc47uCChBO RB4/ZFw5BQMqLqeYWWl8qRim6OdAjlIfn2sn5sLRTuKEJbD0lOFe2/0EVxdGRuCV1GwfcOgpPT2B FczqCobIz501U0YTJFDnEo2OT10I6iniuzIMQU3I4CpIlflYEg64/8OT9R014nUihhm5tPSa1AxO OMSyztJ8o6LElW6X7UYoF91/5NGjVGkwWUQJGndBZdjf/nrd0lcqUCPhNzl2snORt1tpnyu8ok2I RUKjNXvRfinXruyOlJrjmDwtCijIuJzU2HezPjPPU55O9k6u742H3TzV6OZQjfFSBkRKGekJKkBL oI8qOVtTztVLhKUygJGx9rGz/RCOg3LdA2565wQvzJPLSBcCjW5/GWvSdImaww7gqLAjOMc8bzg7 WpCrOOrW9vmmaxoBfuHwvmMXhjEoCjOy/pmb91hEq0/AvhBcgkNo2IVBPgNIIBgcBOxuAXwRcMQS lHVFo0lHErGpBAoaxMYQBk9Q8sglqA9Y7jW1a7PgRuAo3CproSIvYUGuIg3QC27DLTivg/yjE1Cu BIiNE+jvIzmuG1fiQW10ySIUd6lUoOTQPPdhOaIRtPdB+y1PMCxbpBLPiYPTlKtmKgdycvWpwDyf 3MldtIZzDNQgWJSD9JGjtwBMNUVuRhnWxtD44V3RH6bgk7tm1aOPmD8U2nB9LOtdw7/UiuqnvETj 2fSWURDpQZHcfxyUxX1C5T/Kcddx+/I3DVNHHhkSTY8ZFdJEdCB9H6k3J1sHB5p3lALhwFies2aH 8lxh9HPlB1fIE63oIFV/bih4dpHSbOdNOMIruRxG0Yvkdhfcmg8sn2t5X1SZqxRjG+n67yBxqXH3 lk8ei+vteD3uvWFO8WuIH1h+GLiS47T+xGrjvThd84FZiTw0X/yx7GmWdkjALjPGG2r4EXblJzRL oyWQigBwATGKX4YZWDS7rvzKGifSSXcYAQxuKi6kFww7FeYY2ullMPGHagiv+6tJfChT4VWud6Ny fDP8+C6iPB1NSzV3/Agh6JT/76AjLtUEW4sChVbwqg3mQBIaEtQPbsLgLX8gZP2iS6ojhFaLSmvt fpkcnABtg9REIW6UXK0kGSwxsvJyxzznIdzQds++9yfWlPPsSM2AjGq+J9YxWa4k4XrF12mHLePp v8n/+eW5dAPNx03lMYsG8qIIvTQhKIsiY/0goLrCH23bdd9ND27aiChexmeJNIEBEGxY/bPILNZY Fcx3KnbIhggNw+Y0ff2pBcw21k8zrZ9rb3F3I/BX3RwkzUHLrgckbMd8JBCH7fdpvU420T3nUkMY 5Tpo10PEMh/fQCDDUvaACI2aGjbE+y2oDGSLM71tFpm34gVKP5XJsfD04A2VrZvkNVIpRhSkqXPf 4i3JAiVRCWlVUXjsO+W/Jp6A+S++QtV4n3MYhvcn1O9GCZENFJpOmQXqJfCAmuCiKZizH+nsm/kf QwFBJOPALvd4mBj72wbCjn3JSoLvj/BM9WEVbyYKOTZN/i87zpR5CbMYxa+tO0vtby73gUBZfBed 2rR4O91WNQGz1Jswe8c2GcjrzXpZEmJpAcJYkblDGS9zpuikO2XqOlrMWmqp8HalRu1bs2UmrDVs t/PWs1YCamZwkiaPw7wB1i1hB9/rrFiKrU1ea+x7q28YmOTDmpn6oiMGnIamqxhRYsBVWR3EAeg3 mQCfsyZn8eiZJU0idsqf6sXzrwY+Uhvdcw65MkR8VtEY0sIk/GsKAD6z69l51M0Feb0pz7KDwxPe QutviO+88SYlyfzLVnj3gZbsfMzs7Uke5H5RFll2RpBVwhJXK/6AfHMQrMe9js0LW9+///2fTzjT 7e1a2lOGGeUP+BtbTWSnsJxoZTXe/XrKAf8h2HghhzZmrUC3gyyFYlsOB0ttIlgJmkFTtpCaFJt6 eg04w6+XOtw1A5l5VLwEOdBvLJFz4VFomxY7J/xvo8HGop4L9ycOBSFH2wiA66TRUlcllEm0CUnd bAC2qKTs7l4/Xwi55/SRfIE63OPw/f1AlUbkkgoaoaJCvm3LqaiWhGztGbZ7XBQPAAzgEdi4biTR Hx9LnFcu9h8J8mqROtMsgLQ5R8wbcdVXACgSYAPR2NAbhh4hAH/IhDb9vaeDvIxrY8lxRX/NA1as N5gPVHLnwngFgUxYwIrdnKBFlcgFw7J5SrJpyVrMPzxr0M1hPIypvtzUbDPadsy+ge2HvetO09bj 6cLtEkfJ9eVK23IxCGgWOK5iHpCqMPkzifbQVvkw2FqaS7IA74/iT7Y+a+GSO0F0TPFfhtSsx67v AgZC6c03hcyhVSscGR0qnoPSkdYLgtxvepHfATBKKuyBVSG5zzcnxAoc3XA22gH9f52MtGsYhVQI NHgf67iAEJJCZntQSVbniAJJnBaVbEkkQlkcfmIahrr9G4CJc2u8LISPJNTrdkuRDhGXKuQKUaSd 4cjbkKEsuIzmROvs+l5ZF1ugWBZua2hP2KEqxTY7LYSjzyYVji2xqaeUgFjG+XF4E8Ptc0Q9sugW 5vrIiwurrSo1teERKyIsR2p7owVqdIh5LzAgdkY5B8DQPVp9EyqdNim+qycmq1b4lliFMNWv/pO1 mOhGMbp4wcFQMZOqkk1DNmJh7DlJojBfw1Yt3AVL69ZvJob+aDIuO+okdAI71DlWn38r0J7kkX9u mgsHhKzB47AkE21v1+j3OrDfF8UKbAlJUua7OEO0GzPKm3aoUiXduALXShe7yV8PmGTw8TIQFmmq RsSl3ZN1JIahou8CxsVktslIARAodcBH4JWMp/foKqHuxhGoVzKnfrq+ZBHKo1xaN8PRaA22jlml K7VMzPU7F2Zr9w+lDV9thRtdv0zxJV34qfjNHou5ZaIPpoZ/n47iyqALRHzDFX3G662bCB85MedU G7UYKfbixVMFcAnSXsC4cuyrKmui+ovWKWgjSGwiSpSz7P/z465kHnUo/b3+XdmnihCeuYzfH4Xr f3xk2TP56N42ywAOXrE4XO6jgJGmVsJ81RUuZyyI+6/V5t3vuex1vAeTzLiuCDhKZNnQq2/FuuHL qE3EN2dDGGKhSvsstNuNHyVkwD/szmS1kuVSqvsFDAwUNuhe/Jk+9TLpZEmhp41p4E5YSd4yD4cl Di0s0wMqD/1tvOlSaB36+qHefQJZCS8sfvbh/1R9MFReRBOZpHODHnvIv6VVsYOLfRk2dsYL1qBb 9JRflOPFQXGHIYX+FNnKBEtcI4AANEGdjDshe9C5d3nP46qi1M8e1whp36FN7MCI2xujQ/jcNINk 0jIzY+SUZOgs8wRl0182b6GkBJP2AWxYYT2WcH44cZFUAfqmUxhbwFT69S4/SWyvKFj7gyAvH6fU dHIWhSfU+YRx+29YuCQe5XQPQ28yvsSYtZVeIzMH9kGP1PTLO+qGm0obq9cTf+JqBh0ut+CGfYTH /AeKg4EYOyJo1JREyRFl/buE+ijiwwWytn/Ia8i7wonEGoQo9U3Zky6qiXHqPRk64/o5zl/u97Ix N9FSiuJdFbVWToMcZTFVK01Sv3VTU6yVwkjzL3NV+lbzpF6Mcf0jHs07fbQHP4OYnzLT19rKvn0t rSca7MfqOoF38/P845gFNQApjPnjfsV40gfYDCZl4MMcl88vueIqcOnVz5TYAz1dYEcWqljRvKRD XEKVcpuo60ADRmzl/C/XSVA0mUdsBIYCegpLj943ZzmpN3X7doKKe8jsowc3DR32EPCCHxpcpy5/ Wm4pafjaXoUFr7QHZ7/hvfkqgTj34m9oa7BOGp25xBwdWdqT6JLcgOUbhJY2JNNc+aeelmJmAYbb p9OO1ptO2TLhBJEJIufdhlLOqUglTI083V1JRuSwtDQSMXwEfsoe6qvJkPPtjqTxWXfjKzCyWPkK PMR7CAeoQPHosnRmZS0FJcj/aWDtqbGT9USdYRSn1yIA9J5gSotAe3ma/88Q5vOn/eAfrankPw== Print Article

The ALIS eMAR organizes your Pass Meds workflow, generates important documents, and keeps your team informed of important medication details. The Medications Settings page allows you to manage order scheduling functionality and more. 
 

About Medications Settings

Only users with the security role permissions can manage Medications Settings. The majority of these settings are configured at the community level. To access Medications Settings, click the Settings link at the top right corner of your ALIS screen. Then, click Medications

Snag_1672d554.png

There are additional tabs that can be made available to your team within this Medications Settings page: 

For assistance with updating security role permissions and enabling these other eMAR features, contact your Account Manager or our ALIS Customer Success Team

The below guide explains only the contents of the first tab labeled Medications: 

Snag_16666501.png

Med Pass Time Shifts

This section is where you dictate what time the daily med pass time frames will begin and end. There are four required med pass times frames (Morning, Noon, Evening, Hour of Sleep) in ALIS that cover the entire 24 hours in a day.  

The 4 ALIS default Med Pass Time Shifts are: 

  • Morning: 5:00AM - 10:59AM
  • Noon: 11:00AM - 3:29AM
  • Evening: 3:30PM - 7:29PM
  • Hour of Sleep: 7:30PM - 4:59AM

Typically, your Onboarding manager will review these Med Pass Time Shifts settings and make changes with you prior to your scheduled eMAR 'go-live' in ALIS. However, once you've been actively using the ALIS eMAR, you may want to further update the names of your shifts or start times. 

Prior to making any time changes, consult your Account Manager or our ALIS Customer Success Team to ensure times will not interfere with your current Pass Meds workflow. 

It is important to note that updating these time frames, particularly during a shift, can occasionally cause a timeout resulting in some orders to not appear in Pass Meds. 

  • Retry Med Pass Scheduling - While we review and update backend processes for settings to prevent timeouts, this button exists as a manual solution to retry "stamping" the active orders in the current Pass Meds. If a Med Pass Time Shift has recently been changed, and you notice orders disappearing from the MAR, click this button to quickly fix this issue. 

Sort Med Pass by Administration Times

This setting impacts how the Pass Meds page is sorted. The ALIS default is set to Enabled, which is the recommended configuration. When enabled, residents show in order of their earliest scheduled and unrecorded medication in Pass Meds.  

Sort by Administration Times in Pass Meds: 

Snag_1725d926.png

Default Service Level

Default Service Level refers to the method for administering the order. This setting preselects a Service Level when processing or managing orders and impacts how the MAR is stamped. 

The ALIS default is set to Administer, as most Assisted Living licenses "Administer" medications for residents. However, there are other options that may suit your community or state requirements better. It is recommended to select the option here that is most common for your resident medications.

  • If you select the default to be Assistance or Third Party, other toggles appear for you to determine whether or not orders should default to show in the Med Pass, MAR, or Administer PRNS. Snag_173e375f.png
  • Click Save for your change to take effect the next time you process or add a medication. Even with the default you set in your Medications Settings, the Service Level can be adjusted per order, whether processed from the pharmacy or manually added. Refer to these How to Process Incoming Order Messages and How to Manually Add a New Medication guides for more details.

Variance Threshold

This setting determines how long before and after a scheduled med pass time the order will display as being administered "on time" in Pass Meds. The ALIS default is set to "1 hr" for all administration frequencies, and most organizations leave this default for each medication frequency shown here.

Snag_1750bdae.png

  • You can change the variance threshold for orders based on how many times daily the medication is scheduled. Click the Show additional medication frequencies link to expand the table of frequencies options and update using the individual dropdown menus if needed. For more information about how the Variance Threshold affects Pass Meds, read this Why does a medication say "WAIT" or "LATE"? article.

AI Scheduling Hints 

This section contains ALIS legacy settings which you most likely do not need to update. Currently, these scheduling hints may only apply to you if your pharmacy integration is facilitated by Prescriber's Connection. Consult your Account Manager or our ALIS Customer Success Team first to determine if making changes to these settings would benefit your pharmacy connection.  

Will Try Later

With this setting enabled, an additional Will Try Later button is added to the outcome options on the Record Med Pass page. The ALIS default is set to Disabled, and most organizations leave this disabled.

Enabling this option does not impact any medication administration records. The purpose of this Will Try Later button is to have a way for med passers to indicate that they have checked all orders on the Record Med Pass page prior to administration.

When a med passer selects the Will Try Later button, it removes any time and dosage component. Even when clicking the Record Med Pass button, this order will still show as "Outstanding" in the Status column of the main Pass Meds landing page.

Will Try Later in Pass Meds: 

2025-07-23_15-57-35.gifMedication Tags

These settings determine which Medication Tag options are available to select when processing orders from the pharmacy or manually adding and managing orders.

When you use Medication Tags on orders, this creates a badge or badges below a medication name on the Record Med Pass page and the Manage Orders page. These tags also allow you to filter orders by the selected tags in reports, and is particularly useful for the Medication List Report.

  • Default options listed here can be disabled by clicking the Disable button, except for Controlled, Narcotic Drug, and Psychotropic Drug. To learn more about Psychotropic Auto-Tagging, refer to these Psychotropic Auto-Tagging GPI Index and Psychotropic Auto-Tagging Rules guides.
  • You can also create additional tags if needed. Simply click the +Add Tag button, and type the name in the pop-up that appears. Click Submit to save the item to the list and to make available for the next order you attempt to process, add, or edit. 

Snag_1774ab21.png

Physician Orders Disclaimer and Signature Lines

These settings allow you to customize the bottom margin of each page of your resident Physician Orders (POs) documents. The ALIS default POs do not contain a disclaimer statement, and the default  signature lines are Nurse and Physician. 

Snag_1796a60b.png

  • You can add a Disclaimer here to communicate important details about pharmacy policies or a refill authorization statement. To add a disclaimer, type into the open text field and click Save to appear on your POs the next time you view or download the documents.
  • You can also decide if you want to add, edit, or disable any of the signature lines shown on the POs. Click the +Add New Method button to add a signature line, and use the Options button to edit or disable an existing signature line.

Medication Carts

These settings dictate which options are available to select for each resident that will indicate which cart contains all of their orders. If your community organizes your medications on multiple carts, it is highly recommended add the cart names here as it will allow you to efficiently locate orders in Pass Meds. 

Typically, your Onboarding manager will work with you to enable and configure these cart names prior to beginning order processing in your Pharmacy inbox. However, you can update these settings at any time. Any changes you make here will be automatically reflected across ALIS. 

  • To add a new Medication Cart name, click the +Add Medication Cart link, type the name into the open field and click Save. To edit an existing cart name, click into one of the boxes and edit the text directly. Snag_16dc2692.png
  • If you need to delete any existing cart names, click the red X next to the name. Use caution as deleting a cart here also removes the cart from any residents to which it is already assigned.
  • When Medication Carts are configured, you can then manually assign them to each resident. This can be done in the Pharmacies and Manage Orders pages. Snag_16dbef46.png
  • You can also automatically assign Medication Carts to residents based their room assignment. Medication Cart names must first be established in Medications Settings and then added to your Floor Plan settings. To learn more, refer to this How to configure a community Floor Plan guide.

Informational Order Types

These settings allow you to set your Informational Order Types that can be selected when adding orders to residents' Manage Orders pages.

  • ALIS auto-generates a list of order types (Ancillary Orders, Code Status, Dietary Orders, Immunizations, and Lab Orders) that can be disabled by clicking the Options button.
  • To add new order types, click the +Add New Method button at the top of the table, type the name in the pop-up that appears, and click Submit to save. Newly saved order types will be immediately available on the Manage Orders page. To learn more, refer to this Informational Orders guide. 

Community Informationals

When Informationals are added to this section, you can then bulk apply Informationals to multiple residents at a time. The ALIS default does not contain any auto-generated Informationals, and therefore no options will be available until added to these settings.

  • To add a Community Informational, click the +Add Informational button. Use the dropdown menu to select the Type, the options which come from your above Informationals settings. Then, type any details about the order type into the Notes field as it pertains to your residents. 
  • Once created, you can easily bulk apply Community Informationals from this location to residents' Manage Orders pages by multiselecting checkboxes to the left and clicking the Apply to Residents button.

comm_informationals.png

Specialty Settings

History Update Threshold

The ALIS default is set to is "Yesterday". This setting limits how far in the past your med passers can update administration records in the past using Med Pass History. For more information about Med Pass History, read this Med Pass History article.

Bulk Med Pass

This ALIS default is set to Disabled. This setting can be used to bulk record order administration from the main Pass Meds landing page, and it is not commonly enabled. Occasionally this is used during the Onboarding process to quickly generate training data in med pass records. 

  • Bulk Med Pass On Time - This setting appears only when the Bulk Med Pass is enabled. Equally uncommon as above, this setting allows for bulk recording order administration from the Pass Meds landing page that gets recorded as "on time". This occasionally can be leveraged during the Onboarding process to quickly populate MARs for demonstration.

Vitals Validation 

The ALIS default is set to Enabled. This setting restricts the ability to save vitals when the values entered in Pass Meds fall outside of the range that was set when processing or managing orders.

The red validation messaging that appears when a value is not within a range can help prevent incorrect records due to mistypes as well as provide a visual alert for staff that may indicate to them that an order should not be administered due to the vitals taken. Snag_1b83e85b.png

Administration Notes 

The ALIS default is set to Disabled. When enabled, this setting adds an Administration Notes open text field in the Process Order and Manage Orders pages for Routines, PRNs, and Treatments. There are some pharmacy integrations that may entirely prevent you from editing the pharmacy-sent order Instructions field, and most organizations and pharmacies prefer that these instructions are not edited.

The Administration Notes field can be particularly useful for adding more resident-specific instructions (i.e., "Crush tablet into applesauce"), including other order details, or to add custom instructions for med passers that highlight internal operations to follow (i.e., "When vitals fall outside of range, contact RN").

Snag_1b6e7ddf.png

Identify Potential Duplicates 

The ALIS default is set to Disabled. This setting creates an automated alert when processing an incoming order message if the order being processed has identifying features (Order Name, Rx #, etc.) that match an active order on a resident's MAR. Snag_1c2bba93.png

This setting is particularly useful when undergoing pharmacy transitions within ALIS and when you have had to manually add an order that the pharmacy sends later. For more information on how to process and map new orders to existing orders with this setting enabled, refer to this Map New Pharmacy Messages to Existing Orders guide. 

Lock Med Pass Dates and Times

The ALIS default is set to Disabled, meaning that the date and time fields can be edited when recording order administration in Pass Meds. When this setting is enabled, the fields become locked and are not able to be edited. The date and time that auto-populates in this field corresponds to the date and time that the Pass Meds button was clicked on the main Pass Meds landing page.Snag_1c20c864.png

Weight Tracking and Variances

This feature is behind an entitlement and requires an ALIS team member to enable it in order for this option to appear in Specialty Settings. When the entitlement is turned on, you must also move this toggle to Enabled in order for it to be visible in ALIS. For assistance with enabling the entitlement, contact your Account Manager or our ALIS Customer Success Team

Weight Tracking and Variances allows you to see which residents do not have weight records within a specified duration (i.e., One Calendar Month), and if the recorded weight vitals presents a specific percentage(%) or unit (lbs) variance that requires further intervention.

When enabled, this setting creates a Monthly Weights option when you go to Bulk Record Vitals. It also adds a Variances tab in Scheduled Vitals that allows you to bulk record weights and view weight variances. For more general information on how to record vitals, refer to this Recording Vitals guide.Snag_1c716c7e.png

Weight Tracking and Variances

This unique settings section also appears below Specialty Settings when the feature is enabled, and it is where you can manage the weight variances parameters for your community that 

The ALIS default is set to:

  • Product Type: All available company Product Types
  • Duration: One Calendar Month 
  • Percent Change: 5%
  • Unit Change: 5 lbs

To make changes to these default settings, click the Manage button and enter your updated choices in the pane that opens to the right. Click Submit to save.

Snag_1c4379fb.png

Easily copy your parameters to other communities in ALIS by clicking the Copy To button and selecting which environments to copy the settings to. 

For more detailed reporting on weight variances across your company, we can enable the Weight Monitoring Report in your ALIS HQ. Contact your Account Manager or our ALIS Customer Success Team for assistance enabling this dashboard.

MAR Settings 

This setting impacts how much health profile and demographic information from the cover page is also displayed on each page of a resident's MAR. The ALIS default is set to Enabled. 

Simplified MAR example:

Snag_1c79b43e.png

Non-Simplified MAR example: 

Snag_1c7a37a7.png

Medication Exceptions

When an order is not Passed as directed, there are three other options in Pass Meds that are considered "exceptions": Refused, Adverse Reaction, and Other. Out of the box, ALIS provides a required text field when the Other outcome is selected on the Pass Meds page. With this type of setup, the med passer will be prompted to type the exception reason into the text field in order to record medication administration.

Enable Med Pass Exception Options

To accommodate standardization of language when selecting Other in Pass Meds, we have the ability to enable a Medication Exceptions feature, which replaces the open text field with a predetermined and customizable dropdown list of reasons to choose from. 

This Medication Exceptions list feature is behind an entitlement and requires an ALIS team member to enable it. Once the entitlement is turned on, the Med Pass Exception Options must then be enabled per community in your Company Settings page. For assistance, contact your Account Manager or our ALIS Customer Success Team. 

Once you have enabled this feature for a community, you can navigate back to your Medications Settings page. At the bottom of the page, you will find a newly accessible Medication Exception section. This is where you can further customize the ALIS auto-generated list as well as copy newly added items to other community environments.

Snag_170adc08.png

  • To disable any of the auto-generated options, simply click the Disable button to the right of each item.  
  • To add a new exception, click the +Add New button. In the pane that opens to the right, type the Name of the exception item you wish to add to your list. Note that this list will always appear in alphabetical order in Pass Meds for ease of use. 
    •  
      • Once you have created new exception options, you can multiselect and click the Copy To button. This opens a pane to the right for you to choose which other communities in your portfolio you wish to copy these exceptions to. Once you have made your selections, click Send to complete this action.

Snag_170f1583.png

Related Articles:

For more assistance with Medications Settings, 

Contact our ALIS Customer Success Team:

888.404.ALIS (2547) or support@go-alis.com

Was this article helpful?

0 out of 0 found this helpful

Have more questions? Submit a request

Comments

0 comments

Please sign in to leave a comment.